We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Ciena
CIEN
$62.7B
| $1.93M | 0.01% |
31,362
| – | – |
|
677
Summit Therapeutics
SMMT
$11.2B
| $1.93M | 0.01% |
88,000
+24,100
| +38% | +$337K |
|
|
ITCI
678
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.92M | 0.01% |
26,300
+5,000
| +23% | +$376K |
|
679
Houlihan Lokey
HLI
$9.24B
| $1.92M | 0.01% |
12,158
+2,400
| +25% | +$359K |
|
680
Hamilton Lane
HLNE
$5.91B
| $1.92M | 0.01% |
11,400
+4,900
| +75% | +$709K |
|
681
Morningstar
MORN
$7.76B
| $1.91M | 0.01% |
5,972
+400
| +7% | +$124K |
|
682
Trex
TREX
$5.1B
| $1.91M | 0.01% |
28,632
| – | – |
|
683
Glaukos
GKOS
$11.2B
| $1.9M | 0.01% |
14,600
+3,400
| +30% | +$423K |
|
684
Voya Financial
VOYA
$9.16B
| $1.9M | 0.01% |
24,000
| – | – |
|
685
Lattice Semiconductor
LSCC
$18.2B
| $1.9M | 0.01% |
35,800
+7,500
| +27% | +$384K |
|
686
KB Home
KBH
$3.45B
| $1.89M | 0.01% |
22,074
+7,800
| +55% | +$627K |
|
687
Coca-Cola Consolidated
COKE
$12.7B
| $1.89M | 0.01% |
14,330
| – | – |
|
688
Ollie's Bargain Outlet
OLLI
$4.7B
| $1.89M | 0.01% |
19,400
+6,100
| +46% | +$588K |
|
|
AZEK
689
DELISTED
The AZEK Co
AZEK
| $1.87M | 0.01% |
39,900
-3,400
| -8% | -$146K |
|
690
SEI Investments
SEIC
$12.8B
| $1.86M | 0.01% |
26,900
+2,100
| +8% | +$140K |
|
691
Terreno Realty
TRNO
$7.5B
| $1.86M | 0.01% |
27,830
+300
| +1% | +$20.2K |
|
692
SPX Corp
SPXC
$10.6B
| $1.85M | 0.01% |
11,609
+2,200
| +23% | +$332K |
|
693
Dentsply Sirona
XRAY
$2.31B
| $1.84M | 0.01% |
68,100
+25,900
| +61% | +$661K |
|
694
Landstar System
LSTR
$6.4B
| $1.84M | 0.01% |
9,744
+2,200
| +29% | +$406K |
|
695
United Airlines
UAL
$41B
| $1.84M | 0.01% |
32,233
+4,363
| +16% | +$202K |
|
696
Rivian
RIVN
$22.9B
| $1.84M | 0.01% |
163,700
+11,600
| +8% | +$167K |
|
697
The Ensign Group
ENSG
$10.6B
| $1.84M | 0.01% |
12,767
+1,600
| +14% | +$228K |
|
698
GameStop
GME
$8.33B
| $1.83M | 0.01% |
80,000
+13,900
| +21% | +$318K |
|
699
Elanco Animal Health
ELAN
$11.2B
| $1.83M | 0.01% |
124,800
+12,900
| +12% | +$180K |
|
700
Cullen/Frost Bankers
CFR
$10.5B
| $1.82M | 0.01% |
16,316
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.